Category Health/Medical

New Handheld Spectral Analyzer uses Power of Smartphone to detect Disease

The spectral transmission-reflectance-intensity (TRI)-Analyzer attaches to a smartphone and analyzes patient blood, urine, or saliva samples as reliably as clinic-based instruments that cost thousands of dollars. Credit: Department of Bioengineering, University of Illinois at Urbana-Champaign

The spectral transmission-reflectance-intensity (TRI)-Analyzer attaches to a smartphone and analyzes patient blood, urine, or saliva samples as reliably as clinic-based instruments that cost thousands of dollars. Credit: Department of Bioengineering, University of Illinois at Urbana-Champaign

Researchers at the University of Illinois at Urbana-Champaign have developed technology that enables a smartphone to perform lab-grade medical diagnostic tests that typically require large, expensive instruments...

Read More

IV and Cellular Fluids Power Flexible Batteries

1. This is an artistic rendering of fiber-shaped implantable batteries using biocompatible electrolytes. Credit: Guo et al. 2. Guo et al. Multi-functional Flexible Aqueous Sodium-Ion Batteries with High Safety. Chem, 2017 DOI: 10.1016/j.chempr.2017.05.004

1. This is an artistic rendering of fiber-shaped implantable batteries using biocompatible electrolytes.
Credit: Guo et al.
2. Guo et al. Multi-functional Flexible Aqueous Sodium-Ion Batteries with High Safety. Chem, 2017 DOI: 10.1016/j.chempr.2017.05.004

Researchers in China have engineered bendable batteries that can run on body-inspired liquids such as normal IV saline solution and cell-culture medium. In their work the authors designed alternatives to lithium-ion batteries by focusing on the mechanical-stress demands of wearable electronics such as smartwatches and the safety requirements of implantable electronics.

“Current batteries like the lithium-ion ones used in medical implants generally come in rigid shapes,” says Yonggang Wang, a chemistry professor at Fudan University and the C...

Read More

‘Killer Peptide’ discovered that Helps Eliminate Resistant Cancer Cells

Vivek Rangnekar and Ravshan Burikhanov.

UK’s Vivek Rangnekar, left, and Ravshan Burikhanov.

A new study by University of Kentucky Markey Cancer Center researchers shows that when therapy-sensitive cancer cells die, they release a “killer peptide” that can eliminate therapy-resistant cells. Tumor relapse is a common problem following cancer treatment, because primary tumor cells often contain therapy-resistance cancer cells that continue to proliferate after the therapy-sensitive cells have been eliminated.

In the new study, published in Cancer Research, Markey scientists identified a Par-4 amino-terminal fragment (PAF) that is released by diverse therapy-sensitive cancer cells following therapy-induced cleavage of the tumor suppressor Par-4 protein...

Read More

Lizard Venom may contain clues to treating Blood Clots

Associate Professor Bryan Fry with a Komodo dragon

Associate Professor Bryan Fry with a Komodo dragon

Various types of lizard venom are being studied as possible treatments for blood clotting diseases that lead to millions of cases of stroke, heart attack, and DVT annually. University of Queensland School of Biological Sciences expert Associate Professor Bryan Fry said, while snake venom research has been extensive, lizard venom research was still in its infancy.

His latest research – partly titled Enter the Dragon – shines the light on lizards that can serve as potential sources of life-saving medication. “We now know that far more lizards are venomous than previously thought, including the iconic Komodo dragon – the world’s largest lizard,” Dr Fry said...

Read More